The Journal of urology (J Urol)

Journal PubWeight™ 31718.52‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. 1992 13.63
2 Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. 1994 10.03
3 Early detection of prostate cancer: AUA Guideline. 2013 9.14
4 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. 2002 8.73
5 The development of human benign prostatic hyperplasia with age. 1984 8.29
6 Guideline for management of the clinical T1 renal mass. 2009 8.26
7 Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. 2009 6.78
8 Guideline for the management of clinically localized prostate cancer: 2007 update. 2007 6.73
9 The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. 2009 6.71
10 Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. 2010 6.01
11 Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? 2008 5.70
12 Long-term efficacy of sildenafil and tachyphylaxis effect. 2001 5.43
13 The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? 2004 5.41
14 Complications after prostate biopsy: data from SEER-Medicare. 2011 5.40
15 Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. 2004 5.38
16 Imaging use among employed and self-employed urologists. 2010 5.34
17 Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. 1994 5.31
18 Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. 2008 5.30
19 AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. 2003 5.27
20 Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. 1974 5.26
21 Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. 2007 5.24
22 Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. 2007 5.03
23 Update on AUA guideline on the management of benign prostatic hyperplasia. 2011 5.01
24 Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. 2011 4.99
25 Urologic diseases in America project: urolithiasis. 2005 4.90
26 Best practice policy statement on urologic surgery antimicrobial prophylaxis. 2008 4.90
27 Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. 1961 4.88
28 Complications of mid urethral slings: important outcomes for future clinical trials. 2008 4.81
29 Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. 1992 4.79
30 Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. 1989 4.76
31 Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. 2007 4.76
32 Clinical management of foreign bodies of the genitourinary tract. 2000 4.74
33 The changing natural history of renal cell carcinoma. 2001 4.72
34 Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. 2000 4.72
35 Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. 2005 4.69
36 Long-term survival and mortality in prostate cancer treated with noncurative intent. 1995 4.68
37 The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. 2004 4.66
38 Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. 2003 4.66
39 Laparoscopic nephrectomy: initial case report. 1991 4.59
40 An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. 2002 4.59
41 Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. 2013 4.58
42 Contemporary trends in low risk prostate cancer: risk assessment and treatment. 2007 4.56
43 The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. 1993 4.55
44 2007 guideline for the management of ureteral calculi. 2007 4.44
45 Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. 2004 4.41
46 The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. 2005 4.40
47 The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. 1999 4.39
48 The susceptibility of pleuropneumonia-like organisms to the in vitro action of antibiotics: aureomycin, chloramphenicol, dihydrostreptomycin, streptomycin, and sodium penicillin G. 1950 4.38
49 Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. 1976 4.37
50 The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. 2006 4.37
Next 50